Drugs Made In America Acquisition II (DMIIU) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $10.23, +0.00% vs the prior close of $10.23.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DMIIU ends flat (+0.0%) to $10.23, 3 down days in a row. Closed at $10.23, +0.00% vs the prior close of $10.23. Day range $10.23–$10.23, opened at $10.23.
DMIIU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DMIIU ends flat (+0.0%) to $10.23, 3 down days in a row
- Closed at $10.23, +0.00% vs the prior close of $10.23. Day range $10.23–$10.23, opened at $10.23.
- Price is +0.3% vs its 50-day average ($10.20) and +1.1% vs its 200-day average ($10.12).
- 52-week range $9.97–$10.80; today's close sits at 31% of that range, 5.3% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — DMIIU ends flat (+0.0%) to $10.23
- Closed at $10.23, +0.00% vs the prior close of $10.23. Day range $10.23–$10.23, opened at $10.23.
- Price is +0.3% vs its 50-day average ($10.20) and +1.1% vs its 200-day average ($10.12).
- 52-week range $9.97–$10.80; today's close sits at 31% of that range, 5.3% below the 52-week high.
Oct 13, 2026 — DMIIU ends flat (-0.2%) to $10.23 on 10.4x normal volume
- Closed at $10.23, -0.19% vs the prior close of $10.25. Day range $10.23–$10.27, opened at $10.23.
- Volume was 4.20K shares, 10.4x its 50-day average of 404 — unusually heavy trading.
- Price is +0.3% vs its 50-day average ($10.20) and +1.1% vs its 200-day average ($10.12).
- 52-week range $9.97–$10.80; today's close sits at 31% of that range, 5.3% below the 52-week high.
Oct 12, 2026 — DMIIU ends flat (+0.2%) to $10.25 on 11.6x normal volume
- Closed at $10.25, +0.20% vs the prior close of $10.23. Day range $10.21–$10.25, opened at $10.21.
- Volume was 3.80K shares, 11.6x its 50-day average of 328 — unusually heavy trading.
- Price is +0.5% vs its 50-day average ($10.20) and +1.3% vs its 200-day average ($10.12).
- 52-week range $9.96–$10.80; today's close sits at 35% of that range, 5.1% below the 52-week high.
Oct 9, 2026 — DMIIU ends flat (+0.3%) to $10.23 on 4.3x normal volume
- Closed at $10.23, +0.29% vs the prior close of $10.20. Day range $10.23–$10.25, opened at $10.23.
- Volume was 1.30K shares, 4.3x its 50-day average of 302 — unusually heavy trading.
- Price is +0.3% vs its 50-day average ($10.20) and +1.1% vs its 200-day average ($10.11).
- 52-week range $9.96–$10.80; today's close sits at 32% of that range, 5.3% below the 52-week high.
Oct 8, 2026 — DMIIU dips 0.5% to $10.20
- Closed at $10.20, -0.49% vs the prior close of $10.25. Day range $10.20–$10.20, opened at $10.20.
- Volume was 100 shares, 0.3x its 50-day average of 300 — lighter than usual.
- Price is +0.0% vs its 50-day average ($10.19) and +0.9% vs its 200-day average ($10.11).
- 52-week range $9.95–$10.80; today's close sits at 29% of that range, 5.6% below the 52-week high.
Oct 7, 2026 — DMIIU rises 0.5% to $10.25 on 5.1x normal volume
- Closed at $10.25, +0.49% vs the prior close of $10.20. Day range $10.23–$10.25, opened at $10.23.
- Volume was 1.40K shares, 5.1x its 50-day average of 272 — unusually heavy trading.
- Price is +0.5% vs its 50-day average ($10.19) and +1.4% vs its 200-day average ($10.11).
- 52-week range $9.95–$10.80; today's close sits at 35% of that range, 5.1% below the 52-week high.
Oct 6, 2026 — DMIIU ends flat (+0.0%) to $10.20, 9 down days in a row
- Closed at $10.20, +0.00% vs the prior close of $10.20. Day range $10.20–$10.20, opened at $10.20.
- Price is +0.1% vs its 50-day average ($10.19) and +0.9% vs its 200-day average ($10.11).
- 52-week range $9.95–$10.80; today's close sits at 29% of that range, 5.6% below the 52-week high.
- That makes 9 straight losses.
Oct 5, 2026 — DMIIU ends flat (+0.0%) to $10.20, 8 down days in a row
- Closed at $10.20, +0.00% vs the prior close of $10.20. Day range $10.20–$10.20, opened at $10.20.
- Volume was 100 shares, 0.4x its 50-day average of 270 — lighter than usual.
- Price is +0.1% vs its 50-day average ($10.19) and +0.9% vs its 200-day average ($10.11).
- 52-week range $9.95–$10.80; today's close sits at 29% of that range, 5.6% below the 52-week high.
- That makes 8 straight losses.
Oct 2, 2026 — DMIIU ends flat (+0.0%) to $10.20, 7 down days in a row
- Closed at $10.20, +0.00% vs the prior close of $10.20. Day range $10.20–$10.20, opened at $10.20.
- Price is +0.1% vs its 50-day average ($10.19) and +0.9% vs its 200-day average ($10.11).
- 52-week range $9.95–$10.80; today's close sits at 29% of that range, 5.6% below the 52-week high.
- That makes 7 straight losses.
DMIIU latest news & SEC filings
Every SEC filing by or about DMIIU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $4.40M (prior year -$38.07K) (swung to profit vs Jun 30, 2025)
Things to know before you trade DMIIU
- How much it moves: over the last 20 sessions the average daily move was 0.17% (largest 0.5%). That is a relatively calm stock.
- Liquidity: about 985 shares (≈$10.08K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.23 vs a range of $9.97–$10.80 (31% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 2 open-market buys, 2 sales; latest: Made In America Acquisition Ii Llc Drugs bought 700,000 shares on Sep 26, 2025.
- Latest filings: 10-Q Aug 14, 2026; 10-Q May 14, 2026; 8-K Apr 28, 2026.
- Listing: Nasdaq · industry: Blank Checks.
DMIIU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 10.23 | 10.23 | 10.23 | 10.23 | 0 |
| Oct 14, 2026 | 10.23 | 10.23 | 10.23 | 10.23 | 0 |
| Oct 13, 2026 | 10.23 | 10.27 | 10.23 | 10.23 | 4.20K |
| Oct 12, 2026 | 10.21 | 10.25 | 10.21 | 10.25 | 3.80K |
| Oct 9, 2026 | 10.23 | 10.25 | 10.23 | 10.23 | 1.30K |
| Oct 8, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 100 |
| Oct 7, 2026 | 10.23 | 10.25 | 10.23 | 10.25 | 1.40K |
| Oct 6, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 0 |
| Oct 5, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 100 |
| Oct 2, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 0 |
| Oct 1, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 600 |
| Sep 30, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 100 |
| Sep 29, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 0 |
| Sep 28, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 0 |
| Sep 25, 2026 | 10.20 | 10.20 | 10.20 | 10.20 | 100 |
| Sep 24, 2026 | 10.21 | 10.21 | 10.20 | 10.21 | 900 |
| Sep 23, 2026 | 10.24 | 10.24 | 10.24 | 10.24 | 1.00K |
| Sep 22, 2026 | 10.21 | 10.24 | 10.20 | 10.20 | 2.60K |
| Sep 21, 2026 | 10.24 | 10.25 | 10.22 | 10.24 | 1.40K |
| Sep 18, 2026 | 10.24 | 10.25 | 10.22 | 10.25 | 2.10K |
About Drugs Made In America Acquisition II
Drugs Made In America Acquisition II (DMIIU) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in NEW YORK, NY. Fiscal year ends December 31. SEC CIK 2040475.
DMIIU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Catherine Do | Director | Oct 17, 2025 |
| Sridhar G. Prasad | Director | Oct 1, 2025 |
| Myron W. Shulgan | Director | Oct 2, 2025 |
| Lynn Stockwell | CEO and Exe. Chair of Board | Oct 1, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lynn Stockwell | CEO and Exe. Chair of Board | Oct 1, 2025 |
| Glenn C. Worman | CFO | Oct 1, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
| Sep 26, 2025 | Lynn Stockwell | Sale | 7,966,667 | — |
DMIIU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $4.19M | — | $-1.02M |
Latest balance sheet: total assets $514.10M, total liabilities $18.14M, cash $174.97K (as of Jun 30, 2026).
DMIIU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Pyrophyte Acquisition Corp. II (PAII)Karbon Capital Partners (KBON)GalaxyEdge Acquisition (GLED)EQV Ventures Acquisition Corp. II (EVAC)Cohen Circle Acquisition Corp. II (CCII)Graf Global (TONT)Meshflow Acquisition (MESH)Blue Water Acquisition Corp. III (BLUW)Lionheart (CUB)Cantor Equity Partners IV (CEPF)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on DMIIU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.